Epistola Raisa, Do Tiffanie, Vankina Ritika, Wu Daniel, Yeh James, Fleischman Michael W, Lee Jennifer M
Harbor-UCLA Medical Center, Department of Medicine, Torrance, CA, USA.
Harbor-UCLA Medical Center, Department of Medicine, Division of Hematology & Medical Oncology, Torrance, CA, USA.
Case Rep Hematol. 2020 Mar 26;2020:4785759. doi: 10.1155/2020/4785759. eCollection 2020.
While the association of immune thrombocytopenic purpura (ITP) and inflammatory bowel disease (IBD) has been described in a few case reports, management of ITP as an extraintestinal manifestation of Crohn's disease (CD) is less studied. There are approximately a dozen cases describing the management of patients dually diagnosed with CD/ITP. Previous reports postulated that the mechanism of ITP in CD was through the presence of circulating immune complexes in the serum and antigenic mimicry due to increased mucosal permeability in active colitis, versus increased mucosal production of TH1-type proinflammatory cytokines during CD flares, which may account for remission of ITP with surgery for CD. We present a case of a 27-year-old man who presented with medically refractory CD and ITP who responded to surgical management with colectomy and splenectomy, along with a systematic review of the literature. These cases suggest that colectomy should be considered in the treatment of medically refractory ITP among patients with concomitant CD.
虽然在一些病例报告中已描述了免疫性血小板减少性紫癜(ITP)与炎症性肠病(IBD)的关联,但将ITP作为克罗恩病(CD)的肠外表现进行管理的研究较少。大约有十几例病例描述了对同时诊断为CD/ITP患者的管理。先前的报告推测,CD中ITP的机制是血清中循环免疫复合物的存在以及由于活动性结肠炎时粘膜通透性增加导致的抗原模拟,而CD发作期间TH1型促炎细胞因子的粘膜产生增加,这可能解释了CD手术治疗后ITP的缓解。我们报告一例27岁男性患者,患有药物难治性CD和ITP,对结肠切除术和脾切除术的手术治疗有反应,并对文献进行了系统回顾。这些病例表明,对于伴有CD的药物难治性ITP患者,治疗时应考虑结肠切除术。